BACKGROUND: In 2010, the British Association of Dermatologists ( @entity1835 ) published clinical guidelines for the safe introduction and continued use of @entity10211 in @entity1 with acne in the UK. The @entity1835 provides UK dermatologists with a facility for national audit, and it undertook an audit on compliance with these guidelines in 2012. AIM: To determine current clinical practices relating to use of @entity10211 among dermatologists in the UK (including geographical variations) as measured against @entity1835 standards, and to ascertain any improvement since the 2012 audit. METHODS: The 2012 @entity10211 audit proforma was used, with additional questions on clinical setting, complaints and litigation. A web-based survey tool was used for data entry and submission, with email invitation to working, UK-based @entity1835 members (n = 1226) in December 2013 and weekly reminders during the 8.5-week data collection period. Responders were requested to enter data for the three most recent consecutive @entity1 (including one male and one female @entity1 ) who had completed treatment within the previous 6 months. RESULTS: In total, 338 (27.6%) respondents provided data on 1013 patients. Serum lipids were checked in 93.4% of @entity1 and documentation of mental health and/or mood state was recorded in 82.1%. Regarding the @entity2099 ( @entity2099 ), 91.6% of female @entity1 of childbearing potential had signed the @entity2099 information form, while 93.3% who had followed the @entity2099 had taken pregnancy tests both before and during treatment, and 54.7% had taken a pregnancy test 5 weeks post-treatment. CONCLUSION: Overall, there is currently good compliance with standards. Certain aspects of care that are less frequently preformed, such as pregnancy testing post-treatment, are highlighted.

Compliance with national guidelines on @entity10211 : where are we 2 years since the last audit? Results of the National XXXX Re-Audit 2014.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity10211 :: ('MESH:D015474', 'Chemical') :: ['isotretinoin'] @entity2099 :: ('MESH:D011254', 'Disease') :: ['PPP', 'Pregnancy Prevention Programme'] @entity1835 :: ('572', 'Gene') :: ['BAD']
@entity10211 :: (MESH:D015474,Chemical) :: ['Isotretinoin']
